1. Research progress on common adverse events caused by targeted therapy for colorectal cancer (Review)
   Bo Zhang et al, 2018, Oncology Letters CrossRef
2. A Retrospective Look at Anti-EGFR Agents in Pancreatic Cancer Therapy
   Henu K. Verma et al, 2020, Current Drug Metabolism CrossRef
3. Molecular Mechanisms of Renal Magnesium Reabsorption
   David H. Ellison et al, 2021, Journal of the American Society of Nephrology CrossRef
4. Magnesium in Health and Disease
   Andrea M. P. Romani, 2013, Interrelations between Essential Metal Ions and Human Diseases CrossRef
5. Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal Cancer
   Sander Ketzer et al, 2018, Clinical Pharmacokinetics CrossRef
6. Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
   Bryan Oronsky et al, 2017, Cancer Chemotherapy and Pharmacology CrossRef
7. New Pharmaceutical Agents in Oncology
   Christine Cambareri et al, 2016, Physician Assistant Clinics CrossRef
8. Epidermal Growth Factor Receptor Inhibitor-Induced Hypomagnesaemia: Is There a Best Replacement Strategy?
   Zeba Siddiqui et al, 2021, European Medical Journal CrossRef
9. Intérêt du suivi des concentrations de magnésium et de calcium au cours du traitement par panitumumab : à propos d’un cas de détresse respiratoire aiguë
   E. Acero et al, 2020, Le Pharmacien Hospitalier et Clinicien CrossRef
10. Development and implementation of an electrolyte replacement protocol in the outpatient oncology infusion centers of a large academic healthcare system
    Veronica B Ajewole et al, 2020, Journal of Oncology Pharmacy Practice CrossRef
11. Renal Toxicities of Targeted Therapies
    Anum Abbas et al, 2015, Targeted Oncology CrossRef
12. Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature
    JOANNA STREB et al, 2015, Oncology Letters CrossRef
13. Electrolyte Disorders in Cancer Patients
    Sheron Latcha, 2015, Onconephrology CrossRef
14. Renal toxicity of anticancer agents targeting HER2 and EGFR
    Laura Cosmai et al, 2015, Journal of Nephrology CrossRef
15. Management of Epidermal Growth Factor Receptor Inhibitor-Induced Hypomagnesemia: A Systematic Review
    Di (Maria) Jiang et al, 2016, Clinical Colorectal Cancer CrossRef
16. Overcoming Barriers for Clinical Research of Acupuncture
    Wenli Liu et al, 2020, Medical Acupuncture CrossRef
17. The Future Prospective: Potential Magnesium and Calcium for Detracting Side Effect Cisplatin
    Syafika Alaydrus et al, 2022, Research Journal of Pharmacy and Technology CrossRef
18. Renal effects of targeted anticancer therapies
    Camillo Porta et al, 2015, Nature Reviews Nephrology CrossRef
19. Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab
    Tomohiro Enokida et al, 2016, Frontiers in Oncology CrossRef